Loading…

Associations between serum uric acid levels and the incidence of nonfatal stroke: a nationwide community-based cohort study

Background Hyperuricemia is an established risk factor for cardiovascular events and mortality. This study investigated the association between serum uric acid and the incidence of nonfatal stroke in a Japanese community-based population. Methods We used a nationwide database of 155,322 subjects (ag...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and experimental nephrology 2017-06, Vol.21 (3), p.497-503
Main Authors: Kamei, Keita, Konta, Tsuneo, Hirayama, Atsushi, Ichikawa, Kazunobu, Kubota, Isao, Fujimoto, Shouichi, Iseki, Kunitoshi, Moriyama, Toshiki, Yamagata, Kunihiro, Tsuruya, Kazuhiko, Narita, Ichiei, Kondo, Masahide, Shibagaki, Yugo, Kasahara, Masato, Asahi, Koichi, Watanabe, Tsuyoshi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Hyperuricemia is an established risk factor for cardiovascular events and mortality. This study investigated the association between serum uric acid and the incidence of nonfatal stroke in a Japanese community-based population. Methods We used a nationwide database of 155,322 subjects (aged 40–73, male 39 %) who participated in the annual “Specific Health Check and Guidance in Japan” checkup from 2008 to 2010. We examined the relationship between the quintiles of serum uric acid levels at baseline and the incidence of nonfatal stroke during a 2-year study period using self-reported data. Results The crude incidence of nonfatal stroke was significantly associated with serum uric acid levels at baseline, showing the lowest values in subjects with the 3rd quintile (Q3: men, 5.0–5.6; women, 3.8–4.3) of uric acid levels (mg/dL) and the highest values in subjects with the highest quintile (Q5: men ≥7.1, women ≥5.5) both in men and women ( P  
ISSN:1342-1751
1437-7799
DOI:10.1007/s10157-016-1311-7